These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 16673599)

  • 21. In prostatism patients the ratio of human glandular kallikrein to free PSA improves the discrimination between prostate cancer and benign hyperplasia within the diagnostic "gray zone" of total PSA 4 to 10 ng/mL.
    Kwiatkowski MK; Recker F; Piironen T; Pettersson K; Otto T; Wernli M; Tscholl R
    Urology; 1998 Sep; 52(3):360-5. PubMed ID: 9730444
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High serum prostate-specific antigen levels in the absence of prostate cancer in Middle-Eastern men: the clinician's dilemma.
    Kehinde EO; Sheikh M; Mojimoniyi OA; Francis I; Anim JT; Nkansa-Dwamena D; Al-Awadi KA
    BJU Int; 2003 May; 91(7):618-22. PubMed ID: 12699471
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Improved discrimination between prostatic carcinoma and benign prostatic hyperplasia by determination of free prostate-specific antigen percentage].
    Wolff JM; Borchers H; Boeckmann W; Habib FK; Jakse G
    Urologe A; 1997 May; 36(3):255-8. PubMed ID: 9265347
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum prostate-specific antigen as a predictor of prostate volume in men with benign prostatic hyperplasia.
    Roehrborn CG; Boyle P; Gould AL; Waldstreicher J
    Urology; 1999 Mar; 53(3):581-9. PubMed ID: 10096388
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neutrophil-to-lymphocyte and neutrophil-to-monocyte rates in the decision for a prostate re-biopsy in patients with a previous benign pathology and consistently 2,5-10 ng/ml PSA value.
    Ceylan Y; Günlüsoy B; Degirmenci T; Bolat D; Kozacioglu Z; Vardar E; Topçu YK; Polat S
    Arch Esp Urol; 2016 Nov; 69(9):627-635. PubMed ID: 27845694
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of prostate volume measured by transrectal ultrasound and magnetic resonance imaging: is transrectal ultrasound suitable to determine which patients should undergo active surveillance?
    Weiss BE; Wein AJ; Malkowicz SB; Guzzo TJ
    Urol Oncol; 2013 Nov; 31(8):1436-40. PubMed ID: 22503576
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A retrospective comparison between transrectal and transperineal prostate biopsy in the detection of prostate cancer.
    Di Franco CA; Jallous H; Porru D; Giliberto GL; Cebrelli T; Tinelli C; Rovereto B
    Arch Ital Urol Androl; 2017 Mar; 89(1):55-59. PubMed ID: 28403597
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Incidental carcinoma of the prostate.
    van Andel G; Vleeming R; Kurth K; de Reijke TM
    Semin Surg Oncol; 1995; 11(1):36-45. PubMed ID: 7538693
    [TBL] [Abstract][Full Text] [Related]  

  • 29. May ultrasound probe size influence pain perception of needle piercing during transrectal prostate biopsy? A prospective evaluation.
    Fabiani A; Servi L; Filosa A; Fioretti F; Maurelli V; Tombolini F; Tallè M; Mammana G
    Arch Ital Urol Androl; 2016 Oct; 88(3):223-227. PubMed ID: 27711100
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Role of prostate fossa ultrasonography in the diagnosis of local recurrence after radical prostatectomy in case of PSA failure].
    Roscigno M; Scattoni V; Raber M; Consonni P; Montorsi F; Pasta A; Bertini R; Colombo R; Da Pozzo L; Freschi M; Rigatti P
    Arch Ital Urol Androl; 2002 Dec; 74(4):304-8. PubMed ID: 12508759
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum prostate-specific antigen discriminates weakly between men with benign prostatic hyperplasia and patients with organ-confined prostate cancer.
    Sershon PD; Barry MJ; Oesterling JE
    Eur Urol; 1994; 25(4):281-7. PubMed ID: 7519989
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of thymosin beta15 as a urinary biomarker in human prostate cancer.
    Hutchinson LM; Chang EL; Becker CM; Shih MC; Brice M; DeWolf WC; Gaston SM; Zetter BR
    Prostate; 2005 Jul; 64(2):116-27. PubMed ID: 15666387
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Free prostate-specific antigen improves prostate cancer detection in a high-risk population of men with a normal total PSA and digitalrectal examination.
    Uzzo RG; Pinover WH; Horwitz EM; Parlanti A; Mazzoni S; Raysor S; Mirchandani I; Greenberg RE; Pollack A; Hanks GE; Watkins-Bruner D
    Urology; 2003 Apr; 61(4):754-9. PubMed ID: 12670560
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prostate cancer. Mortality and morbidity after non-curative treatment with aspects on diagnosis and treatment.
    Aus G
    Scand J Urol Nephrol Suppl; 1994; 167():1-41. PubMed ID: 7542397
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Post-operative serial prostate-specific antigen and transrectal ultrasound for staging incidental carcinoma of the prostate.
    Feneley MR; Webb JA; McLean A; Kirby RS
    Br J Urol; 1995 Jan; 75(1):14-20. PubMed ID: 7531587
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Detection of prostate carcinoma using prostate specific antigen, its density, and the density of the transition zone in Japanese men with intermediate serum prostate specific antigen concentrations.
    Gohji K; Nomi M; Egawa S; Morisue K; Takenaka A; Okamoto M; Ohori M; Fujii A
    Cancer; 1997 May; 79(10):1969-76. PubMed ID: 9149025
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Repetitive and site-specific molecular staging of prostate cancer using nested reverse transcriptase polymerase chain reaction for prostate specific antigen and prostate specific membrane antigen.
    Koutsilieris M; Lembessis P; Luu-The V; Sourla A
    Clin Exp Metastasis; 1999; 17(10):823-30. PubMed ID: 11089880
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Free and total prostate specific antigen in benign prostate hyperplasia and prostate cancer.
    Naz S; Ahmad S; Ghafoor F; Butt NS; Akhtar MW
    J Coll Physicians Surg Pak; 2004 Feb; 14(2):69-71. PubMed ID: 15228865
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enhanced expression of prostate-specific antigen in the transition zone of the prostate. A characterization following prostatectomy for benign hyperplasia.
    Recker F; Kwiatkowski MK; Pettersson K; Piironen T; Lümmen G; Huber A; Tscholl R
    Eur Urol; 1998; 33(6):549-55. PubMed ID: 9743696
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detection of prostatic carcinoma: the role of TRUS, TRUS guided biopsy, digital rectal examination, PSA and PSA density.
    Men S; Cakar B; Conkbayir I; Hekimoglu B
    J Exp Clin Cancer Res; 2001 Dec; 20(4):473-80. PubMed ID: 11876539
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.